Skip to content

Sunday, May 12, 2024

Latest:

Bridging generations: Combating social isolation in older adults through art and storytelling
Using AI to improve diagnosis of rare genetic disorders
Lyme disease 101: Q&A with Dr. Sarah Gunter
Understanding small bowel obstructions: causes, symptoms and treatment
A mechanism influencing the generation of new COVID variants

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

anti-HER2 therapy

A breast cancer cell dividing. Tubulin is shown in red, mitochondria in green and chromosomes in blue. National Cancer Institute/Wei Qian.

Delivering on the promise of personalized breast cancer therapy

June 13, 2023 anti-HER2 therapy, HER2+ breast cancer, multiparameter molecular classifier, PIK3CA gene, predicting response to therapy, Research

A test predicts with a high degree of confidence which breast cancer patients would benefit the most from a therapy de-escalation approach.

From the Labs Image of the Month:

From the Labs: Faces of embryo development.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951